Pfizer Stock

Pfizer Dividend

The Dividend of Pfizer (PFIZER.NS) as of Aug 13, 2026 is 130.00 INR. In the previous year, Dividend was 35.00 INR — a change of 271.43% (higher).

Dividend

130.00INR

YoY

271.43%

Dividend yield

2.67 %

Last updated:

How much dividend does Pfizer 2026 pay?

According to the latest status from August 2026, Pfizer paid a total of 130.00 INR per share in dividends within the last 12 months. With the current Pfizer price of 4,877.60 INR, this corresponds to a dividend yield of 0.72 %. A dividend is paid times per year.

Pfizer currently offers a dividend yield of about 2.67%. The payout ratio is around 77% of earnings. The dividend has grown at 13.7% per year over the past 20 years.

Historical Pfizer Dividends

A dividend is paid times per year. Last year, the payout months were and August.

PaydateDividend
8/9/2025130.00INR
9/21/202435.00INR
9/11/20235.00INR
10/19/202230.00INR
9/18/202235.00INR
9/11/20215.00INR
9/27/202010.00INR
6/6/2020320.00INR
9/1/201922.50INR
9/29/201820.00INR
9/22/20175.00INR
7/27/201615.00INR
8/3/201512.50INR
1/5/2014360.00INR
9/28/201320.00INR
8/24/201212.50INR
8/8/20114.00INR
2/20/201112.50INR
5/15/201012.50INR
5/1/200912.50INR

Pfizer dividend history and estimates

In 2025, Pfizer paid a dividend amounting to 130.00 INR. Dividend means that Pfizer distributes a portion of its profits to its owners.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Special dividend
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2021
5.00 INR
0.00 INR
320.00 INR
Jan 1, 2022 (e)
65.00 INR
0.00 INR
5.00 INR
Jan 1, 2023
5.00 INR
0.00 INR
30.00 INR
Jan 1, 2024 (e)
35.00 INR
0.00 INR
5.00 INR
Jan 1, 2025
130.00 INR
0.00 INR
0.00 INR
Jan 1, 2026 (e)
130.00 INR
-88.54 INR
130.00 INR
Jan 1, 2027 (e)
0.00 INR
41.46 INR
0.00 INR
Jan 1, 2028 (e)
0.00 INR
49.12 INR
0.00 INR

Is the Pfizer Dividend Safe?

Pfizer has been increasing the dividend for 2 years.

Over the past 10 years, Pfizer has increased it by an annual 26.39%.

Over a five-year period, the distribution dropped by -17.00%.

Analysts expect a Dividend Cut of -43.52% for the current fiscal year.

Pfizer dividend payout ratio

In 2025, Pfizer had a payout ratio of 77.48%. The payout ratio indicates the percentage of the company's profits that Pfizer distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
4.60 %
Jan 1, 2022
48.55 %
Jan 1, 2023
3.67 %
Jan 1, 2024
29.04 %
Jan 1, 2025
77.48 %
Jan 1, 2026 (e)
25.40 %
Jan 1, 2027 (e)
22.93 %
Jan 1, 2028 (e)
24.42 %

Dividend Details

Understanding Pfizer's Dividend Distributions

Pfizer’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Pfizer's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Pfizer's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Pfizer’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Pfizer Stock analysis

What does Pfizer do? Pfizer Ltd is a global biopharmaceutical company based in New York City, USA. The company was founded in 1849 by cousins Charles Pfizer and Charles Erhart, and has achieved numerous milestones in the pharmaceutical industry during its 170-year history. Pfizer's business model is based on the research, development, production, and distribution of innovative drugs and vaccines for a variety of diseases. With a diverse portfolio of products, the company's range extends from drugs for cancer, inflammation, and immunology to neurological and cardiology conditions. Pfizer is a global leader in the development of cancer drugs and has achieved groundbreaking research successes in recent years. Key divisions of the company include oncology, pain management, cardiology, and neurology. Pfizer places great emphasis on putting patients and their needs at the center and works closely with medical professionals, patient groups, and authorities to ensure the best possible patient care. Pfizer is a leading provider of vaccines and has achieved significant breakthroughs in the development of COVID-19 vaccines in recent years. In December 2020, the company was one of the first worldwide to bring a vaccine against the coronavirus to market, making a significant contribution to the fight against the pandemic. In addition to drug research and development, Pfizer is also heavily involved in corporate social responsibility. The company is committed to sustainable development and continuously works to reduce its carbon footprint. The Pfizer Foundation also supports numerous nonprofit organizations and projects in the areas of health, education, and environmental protection. Among Pfizer's most well-known products are medications such as Viagra, Lipitor, and Lyrica, as well as the COVID-19 vaccine Comirnaty. Pfizer has offices in over 150 countries and employs over 90,000 people worldwide. Like any global company, Pfizer faces challenges. The company is often criticized for high drug prices and the availability of medications in developing countries. However, Pfizer actively advocates for access to affordable healthcare and delivers drugs and vaccines to all regions of the world. Overall, Pfizer is a company of great importance in the global healthcare industry. Through its research and development of innovative drugs and vaccines, the company contributes to improving the quality of life for millions of people worldwide. Pfizer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pfizer stock

Over the past 12 months, Pfizer paid a dividend of 130.00 INR . This corresponds to a dividend yield of about 2.67 %. For the coming 12 months, Pfizer is expected to pay a dividend of 41.46 INR.

The current dividend yield of Pfizer is 2.67 %.

Pfizer pays a dividend, distributed in the months of , , , .

Pfizer paid dividends every year for the past 11 years.

For the upcoming 12 months, dividends amounting to 41.46 INR are expected. This corresponds to a dividend yield of 0.85 %.

Pfizer is assigned to the 'Health' sector.

To receive the latest dividend of Pfizer from amounting to 130 INR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Pfizer distributed 5 INR as dividends.

The dividends of Pfizer are distributed in INR.

Dividend calendar 2026
Access this data via the Eulerpool API

All Key Metrics — Pfizer